Date Published
December 12, 2025
Updated For
ALS PCS Version 5.2
#SWORBHPTips
What is ASA?
- Paramedics administer ASA to patients experiencing signs and symptoms of cardiac ischemia
- ASA works by inhibiting cyclooxygenase enzymes (mainly COX-1 and COX-2)
- COX-1 produces Thromboxane A-2 which causes platelet aggregation (clotting)
- Therefore ASA inhibits platelet aggregation
- COX-1 produces Thromboxane A-2 which causes platelet aggregation (clotting)
- With ASA circulating throughout the bloodstream the chances of a new clot forming or an old clot growing is decreased.
What if the patient has already had ASA administered?
- According to the ISIS-2 trial (Lancet, 1988), ASA decreased the mortality in patients experiencing ACS by 23%
- Due to the benefits of ASA in patients experiencing symptoms of cardiac ischemia, your patient may still benefit from ASA administration, even if it was administered prior to your arrival
- This may include patient or family self-administration, or healthcare clinic or office administration
Rationale for more ASA
- Ensures the patient gets the appropriate dose of ASA
- Was the dose taken expired?
- Was it truly ASA?
- No harm in getting an extra dose
- Therapeutic dosing may be up to 1500mg (that is 18 tablets of 80-81mg ASA). From OBHG Companion Document:
Summary
- ASA has been found to decrease mortality and is therefore a helpful treatment in suspected cardiac ischemia
- Paramedics are encouraged to provide ASA even if the patient has already had this medication administered
- Rationale:
- You ensure the patient gets the dose and medication we know helps save lives in cardiac ischemia
- The therapeutic range (1500mg) is far above what an additional dose (or two!) would be
- This includes patient self-administration as well as healthcare provider administered ASA
- Rationale:
Categories
Additional Resources:
No additional resources available for this #SWORBHPTip.





